Global Early Toxicity Testing Market Overview: 2019 – 2027

The Early Toxicity Testing Market was worth USD xx billion in 2019 and is expected to reach approximately USD 1.xx billion by 2025, at a compound annual growth rate of 7.5% during the forecast period. Toxic testing procedures provide more relevant and mechanistic insight into the toxic potential of a chemical the compound, which is introduced the first time on the subject. Early toxicity testing is an important procedure, carried out during all stages of clinical trial phases, to determine Absorption Distribution Metabolism Excretion Toxicity (ADMET) properties of the drug molecule. Toxicity testing help clinicians to know about pharmacokinetic and pharmacodynamics of drug molecule, hence it helps to judge whether the drug is beneficial therapeutic or not for human beings. The report covers detailed competitive landscape including company profiles of key players operating in the global market. Some key players in the early toxicity testing market include Covance, Thermo Fisher Scientific, Quest Diagnostics Corporation, Agilent Technologies. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of Drivers, Restrain, Opportunities and challenges.

Global Early Toxicity Testing Market Dynamics

Technological advancements and rising adoption of both in-vivo & in vitro techniques, driving the global market during the forecast period. Growing research & development activities across the healthcare sector and strict government regulations create the need for toxicity testing for newly invented therapeutic drugs. Advance technology adoption in toxicity testing carried out at newly developed and developing clinical research organizations, drive the global early toxicity testing market. Funds released by governments to support research in the new drug Discovery and Development (NDDD) department is expected to favor the growth of this market. As the overall procedure of toxicity testing studies may not be able to give positive results every time, hence the success rate for new drug approvals remains low due to failures of efficacy and safety. This hampers the growth of the global toxicity testing market.However, certain limitations associated with preclinical testing is restraining the global market.

Global Early Toxicity Testing Market Segment

Global Early Toxicity Testing Market, By Technique

• In vivo • In silico • In vitro Global Early Toxicity Testing Market To know about the Research Methodology :- Request Free Sample Report In-vitro toxicity testing shows a depth understanding of body physiological processes, which helps to find key pathways & pathway components involve in the drug mechanism of action. Preclinical in vivo studies help to determine potential adverse effects of drugs, estimation of safety & efficacy as well as help to understand the mechanism of drug toxicity and decide whether compounds may remain or eliminated from the development process. The pharmaceutical industry develops, validate and implement in vivo technique, a more active testing type in the drug discovery process. Data generated and gathered from In vivo models during toxicity testing is considered as ‘safe’ data for human usage and consumption of drugs. The wide applicability and popularity of early toxicity procedures drive the global early toxicity testing market. In vivo techniques require low amounts of compounds and provide rapid results those help chemists in decision making, which in turn drive the global toxicity testing market in the early and effective discovery of drugs. Flexibility and results of drug toxicity testing during in vivo analysis is relevant to the development plan tailored to each target, hence it creates an opportunity for global market.

Global Early Toxicity Testing Market, By End User

• Pharmaceuticals industry • Cosmetics industry • Chemicals industry • Food industry • Others Scaling up the synthesis of multiple lead drugs require the toxicity testing during drug discovery and preclinical development, drive the global market by pharmacy firms. Pharmaceutical companies are trying to detect potential toxicity of candidate compound at early, which helps in the study of drug pharmacokinetics & pharmacodynamics properties and multiple safety end-points, as a result it leads to large scale manufacturing of the fully efficient and safe drug. The demand for cosmetics and personal care products having beneficial results held the cosmetics industry in the second largest place in the global market. The emerging use of cosmetic products has been driving global early toxicology testing market, in terms of investment in the research & development of newly invented and human safe products.

Global Early Toxicity Testing Market, By Region

• North America • Europe • Asia-Pacific • MEA & Africa • Latin America Global Early Toxicity Testing Market 1 Europe commanded largest market share of xx% in 2019, and it is expected to continue its dominance during the forecast period. Growing research & development related to drug discovery and rapid inventions regarding the launches of therapeutics, cosmetics and others, drive the global early toxicity testing market in Europe. Stringent guidelines and regulations in clinical research during preclinical and clinical trial creates an opportunity for the global market by safety concerns. Other factors that fuel the growth of the market in this region includes the wide and easy availability of toxicity testing devices and products and the presence of highly trained technical professionals. The objective of the report is to present a comprehensive analysis of the Global Healthcare Associated Infections Treatment Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Laryngeal Mirrors Market dynamics, structure by analysing the market segments and projects the Global Laryngeal Mirrors Market size.

Scope of the Global Early Toxicity Testing Market: Inquire before buying

Global Early Toxicity Testing Market, By Technique

• In vivo • In silico • In vitro

Global Early Toxicity Testing Market, By End User

• Pharmaceuticals industry • Cosmetics industry • Chemicals industry • Food industry • Others

Global Early Toxicity Testing Market, By Region

• North America • Europe • Asia-Pacific • MEA & Africa • Latin America

Key Players Operating in the Global Early Toxicity Testing Market

• Covance • Thermo Fisher Scientific • Quest Diagnostics Corporation • Agilent Technologies • Sigma Aldrich • BD bioscience • Bio-rad • Gene Logic • Accelrys • Charles River Laboratories • Ocimum Biosolutions • Eurofins Scientific • Merck KGaA • Evotec AG • Enzo Biochem Inc. • Bioanalytical Systems • General Electric Company • Bruker Corporation • The Jackson Laboratory • Invitrogen • Danaher Corporation • IDBS and PerkinElmer Inc.
Global Early Toxicity Testing Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: EARLY TOXICITY TESTING Market Size, By Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global EARLY TOXICITY TESTING Market Analysis and Forecast 6.1. EARLY TOXICITY TESTING Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global EARLY TOXICITY TESTING Market Analysis and Forecast, By Technique 7.1. Introduction and Definition 7.2. Key Findings 7.3. EARLY TOXICITY TESTING Market Value Share Analysis, By Technique 7.4. EARLY TOXICITY TESTING Market Size (US$ Mn) Forecast, By Technique 7.5. EARLY TOXICITY TESTING Market Analysis, By Technique 7.6. EARLY TOXICITY TESTING Market Attractiveness Analysis, By Technique 8. Global EARLY TOXICITY TESTING Market Analysis and Forecast, By End User 8.1. Introduction and Definition 8.2. Key Findings 8.3. EARLY TOXICITY TESTING Market Value Share Analysis, By End User 8.4. EARLY TOXICITY TESTING Market Size (US$ Mn) Forecast, By End User 8.5. EARLY TOXICITY TESTING Market Analysis, By End User 8.6. EARLY TOXICITY TESTING Market Attractiveness Analysis, By End User 9. Global EARLY TOXICITY TESTING Market Analysis, By Region 9.1. EARLY TOXICITY TESTING Market Value Share Analysis, By Region 9.2. EARLY TOXICITY TESTING Market Size (US$ Mn) Forecast, By Region 9.3. EARLY TOXICITY TESTING Market Attractiveness Analysis, By Region 10. North America EARLY TOXICITY TESTING Market Analysis 10.1. Key Findings 10.2. North America EARLY TOXICITY TESTING Market Overview 10.3. North America EARLY TOXICITY TESTING Market Value Share Analysis, By Technique 10.4. North America EARLY TOXICITY TESTING Market Forecast, By Technique 10.4.1. In vivo 10.4.2. In silico 10.4.3. In vitro 10.5. North America EARLY TOXICITY TESTING Market Value Share Analysis, By End User 10.6. North America EARLY TOXICITY TESTING Market Forecast, By End User 10.6.1. Pharmaceuticals industry 10.6.2. Cosmetics industry 10.6.3. Chemicals industry 10.6.4. Food industry 10.6.5. Others 10.7. North America EARLY TOXICITY TESTING Market Value Share Analysis, By Country 10.8. North America EARLY TOXICITY TESTING Market Forecast, By Country 10.8.1. U.S. 10.8.2. Canada 10.8.3. Mexico 10.9. North America EARLY TOXICITY TESTING Market Analysis, By Country 10.10. U.S. EARLY TOXICITY TESTING Market Forecast, By Technique 10.10.1. In vivo 10.10.2. In silico 10.10.3. In vitro 10.11. U.S. EARLY TOXICITY TESTING Market Forecast, By End User 10.11.1. Pharmaceuticals industry 10.11.2. Cosmetics industry 10.11.3. Chemicals industry 10.11.4. Food industry 10.11.5. Others 10.12. Canada EARLY TOXICITY TESTING Market Forecast, By Technique 10.12.1. In vivo 10.12.2. In silico 10.12.3. In vitro 10.13. Canada EARLY TOXICITY TESTING Market Forecast, By End User 10.13.1. Pharmaceuticals industry 10.13.2. Cosmetics industry 10.13.3. Chemicals industry 10.13.4. Food industry 10.13.5. Others 10.14. Mexico EARLY TOXICITY TESTING Market Forecast, By Technique 10.14.1. In vivo 10.14.2. In silico 10.14.3. In vitro 10.15. Mexico EARLY TOXICITY TESTING Market Forecast, By End User 10.15.1. Pharmaceuticals industry 10.15.2. Cosmetics industry 10.15.3. Chemicals industry 10.15.4. Food industry 10.15.5. Others 10.16. North America EARLY TOXICITY TESTING Market Attractiveness Analysis 10.16.1. By Technique 10.16.2. By End User 10.17. PEST Analysis 10.18. Key Trends 10.19. Key Developments 11. Europe EARLY TOXICITY TESTING Market Analysis 11.1. Key Findings 11.2. Europe EARLY TOXICITY TESTING Market Overview 11.3. Europe EARLY TOXICITY TESTING Market Value Share Analysis, By Technique 11.4. Europe EARLY TOXICITY TESTING Market Forecast, By Technique 11.4.1. In vivo 11.4.2. In silico 11.4.3. In vitro 11.5. Europe EARLY TOXICITY TESTING Market Value Share Analysis, By End User 11.6. Europe EARLY TOXICITY TESTING Market Forecast, By End User 11.6.1. Pharmaceuticals industry 11.6.2. Cosmetics industry 11.6.3. Chemicals industry 11.6.4. Food industry 11.6.5. Others 11.7. Europe EARLY TOXICITY TESTING Market Value Share Analysis, By Country 11.8. Europe EARLY TOXICITY TESTING Market Forecast, By Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Sweden 11.8.7. CIS countries 11.8.8. Rest of Europe 11.9. Germany EARLY TOXICITY TESTING Market Forecast, By Technique 11.9.1. In vivo 11.9.2. In silico 11.9.3. In vitro 11.10. Germany EARLY TOXICITY TESTING Market Forecast, By End User 11.10.1. Pharmaceuticals industry 11.10.2. Cosmetics industry 11.10.3. Chemicals industry 11.10.4. Food industry 11.10.5. Others 11.11. U.K. EARLY TOXICITY TESTING Market Forecast, By Technique 11.11.1. In vivo 11.11.2. In silico 11.11.3. In vitro 11.12. U.K. EARLY TOXICITY TESTING Market Forecast, By End User 11.12.1. Pharmaceuticals industry 11.12.2. Cosmetics industry 11.12.3. Chemicals industry 11.12.4. Food industry 11.12.5. Others 11.13. France EARLY TOXICITY TESTING Market Forecast, By Technique 11.13.1. In vivo 11.13.2. In silico 11.13.3. In vitro 11.14. France EARLY TOXICITY TESTING Market Forecast, By End User 11.14.1. Pharmaceuticals industry 11.14.2. Cosmetics industry 11.14.3. Chemicals industry 11.14.4. Food industry 11.14.5. Others 11.15. Italy EARLY TOXICITY TESTING Market Forecast, By Technique 11.15.1. In vivo 11.15.2. In silico 11.15.3. In vitro 11.16. Italy EARLY TOXICITY TESTING Market Forecast, By End User 11.16.1. Pharmaceuticals industry 11.16.2. Cosmetics industry 11.16.3. Chemicals industry 11.16.4. Food industry 11.16.5. Others 11.17. Spain EARLY TOXICITY TESTING Market Forecast, By Technique 11.17.1. In vivo 11.17.2. In silico 11.17.3. In vitro 11.18. Spain EARLY TOXICITY TESTING Market Forecast, By End User 11.18.1. Pharmaceuticals industry 11.18.2. Cosmetics industry 11.18.3. Chemicals industry 11.18.4. Food industry 11.18.5. Others 11.19. Sweden EARLY TOXICITY TESTING Market Forecast, By Technique 11.19.1. In vivo 11.19.2. In silico 11.19.3. In vitro 11.20. Sweden EARLY TOXICITY TESTING Market Forecast, By End User 11.20.1. Pharmaceuticals industry 11.20.2. Cosmetics industry 11.20.3. Chemicals industry 11.20.4. Food industry 11.20.5. Others 11.21. CIS countries EARLY TOXICITY TESTING Market Forecast, By Technique 11.21.1. In vivo 11.21.2. In silico 11.21.3. In vitro 11.22. CIS countries EARLY TOXICITY TESTING Market Forecast, By End User 11.22.1. Pharmaceuticals industry 11.22.2. Cosmetics industry 11.22.3. Chemicals industry 11.22.4. Food industry 11.22.5. Others 11.23. Rest of Europe EARLY TOXICITY TESTING Market Forecast, By Technique 11.23.1. In vivo 11.23.2. In silico 11.23.3. In vitro 11.24. Rest of Europe EARLY TOXICITY TESTING Market Forecast, By End User 11.24.1. Pharmaceuticals industry 11.24.2. Cosmetics industry 11.24.3. Chemicals industry 11.24.4. Food industry 11.24.5. Others 11.25. Europe EARLY TOXICITY TESTING Market Attractiveness Analysis 11.25.1. By End User 11.25.2. By Technique 11.26. PEST Analysis 11.27. Key Trends 11.28. Key Developments 12. Asia Pacific EARLY TOXICITY TESTING Market Analysis 12.1. Key Findings 12.2. Asia Pacific EARLY TOXICITY TESTING Market Overview 12.3. Asia Pacific EARLY TOXICITY TESTING Market Value Share Analysis, By Technique 12.4. Asia Pacific EARLY TOXICITY TESTING Market Forecast, By Technique 12.4.1. In vivo 12.4.2. In silico 12.4.3. In vitro 12.5. Asia Pacific EARLY TOXICITY TESTING Market Value Share Analysis, By End User 12.6. Asia Pacific EARLY TOXICITY TESTING Market Forecast, By End User 12.6.1. Pharmaceuticals industry 12.6.2. Cosmetics industry 12.6.3. Chemicals industry 12.6.4. Food industry 12.6.5. Others 12.7. Asia Pacific EARLY TOXICITY TESTING Market Value Share Analysis, By Country 12.8. Asia Pacific EARLY TOXICITY TESTING Market Forecast, By Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. South Korea 12.8.5. Australia 12.8.6. ASEAN 12.8.7. Rest of Asia Pacific 12.9. Asia Pacific EARLY TOXICITY TESTING Market Analysis, By Country 12.10. China EARLY TOXICITY TESTING Market Forecast, By Technique 12.10.1. In vivo 12.10.2. In silico 12.10.3. In vitro 12.11. China EARLY TOXICITY TESTING Market Forecast, By End User 12.11.1. Pharmaceuticals industry 12.11.2. Cosmetics industry 12.11.3. Chemicals industry 12.11.4. Food industry 12.11.5. Others 12.12. India EARLY TOXICITY TESTING Market Forecast, By Technique 12.12.1. In vivo 12.12.2. In silico 12.12.3. In vitro 12.13. India EARLY TOXICITY TESTING Market Forecast, By End User 12.13.1. Pharmaceuticals industry 12.13.2. Cosmetics industry 12.13.3. Chemicals industry 12.13.4. Food industry 12.13.5. Others 12.14. Japan EARLY TOXICITY TESTING Market Forecast, By Technique 12.14.1. In vivo 12.14.2. In silico 12.14.3. In vitro 12.15. Japan EARLY TOXICITY TESTING Market Forecast, By End User 12.15.1. Pharmaceuticals industry 12.15.2. Cosmetics industry 12.15.3. Chemicals industry 12.15.4. Food industry 12.15.5. Others 12.16. South Korea EARLY TOXICITY TESTING Market Forecast, By Technique 12.16.1. In vivo 12.16.2. In silico 12.16.3. In vitro 12.17. South Korea EARLY TOXICITY TESTING Market Forecast, By End User 12.17.1. Pharmaceuticals industry 12.17.2. Cosmetics industry 12.17.3. Chemicals industry 12.17.4. Food industry 12.17.5. Others 12.18. Australia EARLY TOXICITY TESTING Market Forecast, By Technique 12.18.1. In vivo 12.18.2. In silico 12.18.3. In vitro 12.19. Australia EARLY TOXICITY TESTING Market Forecast, By End User 12.19.1. Pharmaceuticals industry 12.19.2. Cosmetics industry 12.19.3. Chemicals industry 12.19.4. Food industry 12.19.5. Others 12.20. ASEAN EARLY TOXICITY TESTING Market Forecast, By Technique 12.20.1. In vivo 12.20.2. In silico 12.20.3. In vitro 12.21. ASEAN EARLY TOXICITY TESTING Market Forecast, By End User 12.21.1. Pharmaceuticals industry 12.21.2. Cosmetics industry 12.21.3. Chemicals industry 12.21.4. Food industry 12.21.5. Others 12.22. Rest of Asia Pacific EARLY TOXICITY TESTING Market Forecast, By Technique 12.22.1. In vivo 12.22.2. In silico 12.22.3. In vitro 12.23. Rest of Asia Pacific EARLY TOXICITY TESTING Market Forecast, By End User 12.23.1. Pharmaceuticals industry 12.23.2. Cosmetics industry 12.23.3. Chemicals industry 12.23.4. Food industry 12.23.5. Others 12.24. Asia Pacific EARLY TOXICITY TESTING Market Attractiveness Analysis 12.24.1. By Technique 12.24.2. By End User 12.25. PEST Analysis 12.26. Key Trends 12.27. Key Developments 13. Middle East & Africa EARLY TOXICITY TESTING Market Analysis 13.1. Key Findings 13.2. Middle East & Africa EARLY TOXICITY TESTING Market Overview 13.3. Middle East & Africa EARLY TOXICITY TESTING Market Value Share Analysis, By Technique 13.4. Middle East & Africa EARLY TOXICITY TESTING Market Forecast, By Technique 13.4.1. In vivo 13.4.2. In silico 13.4.3. In vitro 13.5. Middle East & Africa EARLY TOXICITY TESTING Market Value Share Analysis, By End User 13.6. Middle East & Africa EARLY TOXICITY TESTING Market Forecast, By End User 13.6.1. Pharmaceuticals industry 13.6.2. Cosmetics industry 13.6.3. Chemicals industry 13.6.4. Food industry 13.6.5. Others 13.7. Middle East & Africa EARLY TOXICITY TESTING Market Value Share Analysis, By Country 13.8. Middle East & Africa EARLY TOXICITY TESTING Market Forecast, By Country 13.8.1. GCC Countries 13.8.2. South Africa 13.8.3. Nigeria 13.8.4. Egypt 13.8.5. Rest of Middle East & Africa 13.9. Middle East & Africa EARLY TOXICITY TESTING Market Analysis, By Country 13.10. GCC Countries EARLY TOXICITY TESTING Market Forecast, By Technique 13.10.1. In vivo 13.10.2. In silico 13.10.3. In vitro 13.11. GCC Countries EARLY TOXICITY TESTING Market Forecast, By End User 13.11.1. Pharmaceuticals industry 13.11.2. Cosmetics industry 13.11.3. Chemicals industry 13.11.4. Food industry 13.11.5. Others 13.12. South Africa EARLY TOXICITY TESTING Market Forecast, By Technique 13.12.1. In vivo 13.12.2. In silico 13.12.3. In vitro 13.13. South Africa EARLY TOXICITY TESTING Market Forecast, By End User 13.13.1. Pharmaceuticals industry 13.13.2. Cosmetics industry 13.13.3. Chemicals industry 13.13.4. Food industry 13.13.5. Others 13.14. Nigeria EARLY TOXICITY TESTING Market Forecast, By Technique 13.14.1. In vivo 13.14.2. In silico 13.14.3. In vitro 13.15. Nigeria EARLY TOXICITY TESTING Market Forecast, By End User 13.15.1. Pharmaceuticals industry 13.15.2. Cosmetics industry 13.15.3. Chemicals industry 13.15.4. Food industry 13.15.5. Others 13.16. Egypt EARLY TOXICITY TESTING Market Forecast, By Technique 13.16.1. In vivo 13.16.2. In silico 13.16.3. In vitro 13.17. Egypt EARLY TOXICITY TESTING Market Forecast, By End User 13.17.1. Pharmaceuticals industry 13.17.2. Cosmetics industry 13.17.3. Chemicals industry 13.17.4. Food industry 13.17.5. Others 13.18. Rest of Middle East & Africa EARLY TOXICITY TESTING Market Forecast, By Technique 13.18.1. In vivo 13.18.2. In silico 13.18.3. In vitro 13.19. Rest of Middle East & Africa EARLY TOXICITY TESTING Market Forecast, By End User 13.19.1. Pharmaceuticals industry 13.19.2. Cosmetics industry 13.19.3. Chemicals industry 13.19.4. Food industry 13.19.5. Others 13.20. Middle East & Africa EARLY TOXICITY TESTING Market Attractiveness Analysis 13.20.1. By Technique 13.20.2. By End User 13.21. PEST Analysis 13.22. Key Trends 13.23. Key Developments 14. South America EARLY TOXICITY TESTING Market Analysis 14.1. Key Findings 14.2. South America EARLY TOXICITY TESTING Market Overview 14.3. South America EARLY TOXICITY TESTING Market Value Share Analysis, By Technique 14.4. South America EARLY TOXICITY TESTING Market Forecast, By Technique 14.4.1. In vivo 14.4.2. In silico 14.4.3. In vitro 14.5. South America EARLY TOXICITY TESTING Market Value Share Analysis, By End User 14.6. South America EARLY TOXICITY TESTING Market Forecast, By End User 14.6.1. Pharmaceuticals industry 14.6.2. Cosmetics industry 14.6.3. Chemicals industry 14.6.4. Food industry 14.6.5. Others 14.7. South America EARLY TOXICITY TESTING Market Value Share Analysis, By Country 14.8. South America EARLY TOXICITY TESTING Market Forecast, By Country 14.8.1. Brazil 14.8.2. Colombia 14.8.3. Argentina 14.8.4. Rest of South America 14.9. South America EARLY TOXICITY TESTING Market Analysis, By Country 14.10. Brazil EARLY TOXICITY TESTING Market Forecast, By Technique 14.10.1. In vivo 14.10.2. In silico 14.10.3. In vitro 14.11. Brazil EARLY TOXICITY TESTING Market Forecast, By End User 14.11.1. Pharmaceuticals industry 14.11.2. Cosmetics industry 14.11.3. Chemicals industry 14.11.4. Food industry 14.11.5. Others 14.12. Colombia EARLY TOXICITY TESTING Market Forecast, By Technique 14.12.1. In vivo 14.12.2. In silico 14.12.3. In vitro 14.13. Colombia EARLY TOXICITY TESTING Market Forecast, By End User 14.13.1. Pharmaceuticals industry 14.13.2. Cosmetics industry 14.13.3. Chemicals industry 14.13.4. Food industry 14.13.5. Others 14.14. Argentina EARLY TOXICITY TESTING Market Forecast, By Technique 14.14.1. In vivo 14.14.2. In silico 14.14.3. In vitro 14.15. Argentina EARLY TOXICITY TESTING Market Forecast, By End User 14.15.1. Pharmaceuticals industry 14.15.2. Cosmetics industry 14.15.3. Chemicals industry 14.15.4. Food industry 14.15.5. Others 14.16. Rest of South America EARLY TOXICITY TESTING Market Forecast, By Technique 14.16.1. In vivo 14.16.2. In silico 14.16.3. In vitro 14.17. Rest of South America EARLY TOXICITY TESTING Market Forecast, By End User 14.17.1. Pharmaceuticals industry 14.17.2. Cosmetics industry 14.17.3. Chemicals industry 14.17.4. Food industry 14.17.5. Others 14.18. South America EARLY TOXICITY TESTING Market Attractiveness Analysis 14.18.1. By Technique 14.18.2. By End User 14.19. PEST Analysis 14.20. Key Trends 14.21. Key Developments 15. Company Profiles 15.1. Market Share Analysis, By Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players By price, presence, market share, Component, and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A By Regions, Investment and Component 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Covance 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Development Footprint 15.3.2. Thermo Fisher Scientific 15.3.3. Quest Diagnostics Corporation 15.3.4. Agilent Technologies 15.3.5. Sigma Aldrich 15.3.6. BD bioscience 15.3.7. Bio-rad 15.3.8. Gene Logic 15.3.9. Accelrys 15.3.10. Charles River Laboratories 15.3.11. Ocimum Biosolutions 15.3.12. Eurofins Scientific 15.3.13. Merck KGaA 15.3.14. Evotec AG 15.3.15. Enzo Biochem Inc. 15.3.16. Bioanalytical Systems 15.3.17. General Electric Company 15.3.18. Bruker Corporation 15.3.19. The Jackson Laboratory 15.3.20. Invitrogen 15.3.21. Danaher Corporation 15.3.22. IDBS and PerkinElmer Inc. 16. Primary key Insights

About This Report

Report ID 81938
Category Healthcare
Published Date February 2021
Updated Date
Contact Us